National Advisory Committee on Rural Health and Human Services, 5670-5671 [2020-01810]
Download as PDF
5670
Federal Register / Vol. 85, No. 21 / Friday, January 31, 2020 / Notices
approach if it satisfies the requirements
of the applicable statutes and
regulations.
II. Paperwork Reduction Act of 1995
This draft guidance refers to
previously approved collections of
information found in FDA regulations.
These collections of information are
subject to review by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995
(44 U.S.C. 3501–3521). The collections
of information in 21 CFR 601.12 and
Form FDA 356h have been approved
under OMB control number 0910–0338;
the collections of information in 21 CFR
parts 610 and 630 have been approved
under OMB control numbers 0910–
0116.
III. Electronic Access
Persons with access to the internet
may obtain the draft guidance at either
https://www.fda.gov/vaccines-bloodbiologics/guidance-complianceregulatory-information-biologics/
biologics-guidances or https://
www.regulations.gov.
Dated: January 27, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020–01815 Filed 1–30–20; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the CDC/HRSA Advisory
Committee on HIV, Viral Hepatitis and
STD Prevention and Treatment
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Centers for
Disease Control and Prevention (CDC)/
HRSA Advisory Committee on HIV,
Viral Hepatitis and STD Prevention and
Treatment (CHAC) has scheduled a
public meeting. Information about
CHAC can be found at https://
www.cdc.gov/maso/facm/facm
CHACHSPT.html.
DATES: March 5, 2020, 3:00 p.m.—4:00
p.m. Eastern Time (ET).
ADDRESSES: This meeting will be held
by webinar and will accommodate up to
100 attendees. To access the virtual
meeting, please use the information
below.
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:16 Jan 30, 2020
Jkt 250001
• Webinar link: https://
hrsa.connectsolutions.com/chac_
business_meeting/
• Conference call-in number:
Æ Call in: 888–790–1964.
Æ Passcode: 1251991.
and phone number listed above at least
10 business days prior to the meeting.
Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2020–01809 Filed 1–30–20; 8:45 am]
BILLING CODE 4165–15–P
FOR FURTHER INFORMATION CONTACT:
Theresa Jumento, Public Health
Advisor, HIV/AIDS Bureau, HRSA, 5600
Fishers Lane, Rockville, Maryland
20857; 301–443–5807; or
CHACAdvisoryComm@hrsa.gov.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
CHAC was
established under Section 222 of the
Public Health Service (PHS) Act, [42
U.S.C. Section 217a], as amended.
The purpose of CHAC is to advise the
Secretary of HHS, the Director of CDC,
and the HRSA Administrator regarding
objectives, strategies, policies, and
priorities for HIV, viral hepatitis, and
other STDs; prevention and treatment
efforts including surveillance of HIV
infection, viral hepatitis, other STDs,
and related behaviors; epidemiologic,
behavioral, health services, and
laboratory research on HIV, viral
hepatitis, and other STDs; identification
of policy issues related to HIV/viral
hepatitis/STD professional eduction,
patient healthcare delivery, and
prevention services; agency policies
about prevention of HIV, viral hepatitis
and other STDs; treatment, healthcare
delivery, and research and training;
strategic issues influencing the ability of
CDC and HRSA to fulfill their missions
of providing prevention and treatment
services; programmatic efforts to
prevent and treat HIV, viral hepatitis,
and other STDs; and support to the
agencies in their developoment of
responses to emerging health needs
related to HIV, viral hepatitis, and other
STDs.
During the March 5, 2020, meeting,
CHAC will discuss issues related to a
CDC pilot on recency assay-based
incidence estimation and the President’s
initiative on ‘‘Ending the HIV Epidemic:
A Plan for America.’’ Agenda items are
subject to change as priorities dictate.
Due to the nature and time limitations
of the meeting, members of the public
will not have an opportunity to provide
oral comments, although written
comments may be submitted prior to the
meeting, or up to 5 business days after
the meeting, to Theresa Jumento at the
contact information listed above.
Individuals who plan to attend and
need special assistance or another
reasonable accommodation should
notify Theresa Jumento at the address
National Advisory Committee on Rural
Health and Human Services
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Health Resources and Services
Administration
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Secretary’s
National Advisory Committee on Rural
Health and Human Services
(NACRHHS) has scheduled a public
meeting. Information about NACRHHS
and the agenda for this meeting can be
found on the NACRHHS website at
https://www.hrsa.gov/advisorycommittees/rural-health/.
DATES: March 2, 2020, 8:30 a.m.–5:15
p.m. Eastern Time (ET); March 3, 2020,
8:30 a.m.–5:15 p.m. ET; and March 4,
2020, 8:30 a.m.–11:15 a.m. ET.
ADDRESSES: The address for the meeting
is the Center for Disease Control and
Prevention (CDC) Global
Communications Center (GCC)
Auditorium B3, 1600 Clifton Road,
Atlanta, GA 30329.
On the morning of March 3, 2020,
NACRHHS will break into
subcommittees. One subcommittee will
travel to Mercer School of Medicine,
1550 College St., Macon, GA 31207. The
other subcommittee will travel to Health
Services Center, 608 Martin Luther King
Drive, Hobson City, AL 36201. In the
afternoon, at approximately 4:00 p.m.
ET., NACRHHS will reconvene at the
CDC GCC.
FOR FURTHER INFORMATION CONTACT:
Steven Hirsch, Administrative
Coordinator at the Federal Office of
Rural Health Policy, HRSA, 5600
Fishers Lane, 17W59D, Rockville,
Maryland 20857; 301–443–7322; or
shirsch@hrsa.gov.
SUPPLEMENTARY INFORMATION:
NACRHHS provides advice and
recommendations to the Secretary of
HHS (Secretary) on policy, program
development, and other matters of
significance concerning both rural
health and rural human services.
SUMMARY:
E:\FR\FM\31JAN1.SGM
31JAN1
Federal Register / Vol. 85, No. 21 / Friday, January 31, 2020 / Notices
During the March 2–4, 2020, meeting,
NACRHHS will examine two topics:
Maternal and Obstetric Care Challenges
in Rural America and HIV Prevention
and Treatment Challenges in Rural
America. Refer to the NACRHHS
website for any updated information
concerning the meeting.
Members of the public will have the
opportunity to provide comments.
Public participants may submit written
statements in advance of the scheduled
meeting. Oral comments will be
honored in the order they are requested
and may be limited as time allows.
Requests to submit a written statement
or make oral comments to NACRHHS
should be sent to Steven Hirsch, using
the contact information above, at least 3
business days prior to the meeting.
Individuals who plan to attend and
need special assistance or another
reasonable accommodation should
notify Steven Hirsch at the address and
phone number listed above at least 10
business days prior to the meeting.
Since the meeting at the CDC occurs in
a federal government building,
attendees must go through a security
check to enter the building. Non-U.S.
Citizen attendees must notify Steven
Hirsch of their planned attendance at
least 20 business days prior to the
meeting in order to facilitate their entry
into the building. All attendees are
required to present government-issued
identification prior to entry.
Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2020–01810 Filed 1–30–20; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the National Clinical Care
Commission
Office of Disease Prevention
and Health Promotion, Office of the
Assistant Secretary for Health, Office of
the Secretary, Department of Health and
Human Services.
AGENCY:
ACTION:
Notice.
The National Clinical Care
Commission (the Commission) will
conduct a virtual meeting on February
19, 2020. The Commission is charged to
evaluate and make recommendations to
the U.S. Department of Health and
Human Services (HHS) Secretary and
Congress regarding improvements to the
coordination and leveraging of federal
programs related to diabetes and its
complications.
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:16 Jan 30, 2020
Jkt 250001
The meeting will take place on
February 19, 2020, from 1 p.m. to
approximately 5 p.m. Eastern Standard
Time (EST).
ADDRESSES: The meeting will be held
online via webinar. To register to attend
the meeting, please visit the registration
website at https://
kauffmaninc.adobeconnect.com/nccc_
feb2020/event/event_info.html.
FOR FURTHER INFORMATION CONTACT:
Linda Harris, Designated Federal
Officer, National Clinical Care
Commission, U.S. Department of Health
and Human Services, Office of the
Assistant Secretary for Health, Office of
Disease Prevention and Health
Promotion, 1101 Wootton Parkway,
Suite 420, Rockville, MD 20852. Email:
OHQ@hhs.gov. Telephone: 240–453–
8262.
SUPPLEMENTARY INFORMATION: The
National Clinical Care Commission Act
(Pub. L. 115–80) requires the HHS
Secretary to establish the National
Clinical Care Commission. The
Commission consists of representatives
of specific federal agencies and nonfederal individuals and entities who
represent diverse disciplines and views.
The Commission will evaluate and
make recommendations to the HHS
Secretary and Congress regarding
improvements to the coordination and
leveraging of federal programs related to
diabetes and its complications.
The sixth meeting will be held
virtually, and will consist of
presentations from the Centers for
Medicare and Medicaid Services (CMS).
The final meeting agenda will be
available prior to the meeting at https://
health.gov/hcq/national-clinical-carecommission.asp.
Public Participation at Meeting: The
Commission invites public comment on
issues related to the Commission’s
charge. There will be an opportunity for
oral comments at this virtual meeting.
Virtual attendees who plan to provide
oral comments at the Commission
meeting during a designated time must
register prior to the meeting. To
virtually attend the Commission
meeting, individuals must pre-register at
the registration website at https://
kauffmaninc.adobeconnect.com/nccc_
feb2020/event/event_info.html.
Written comments are welcome
throughout the entire development
process of the Commission’s work and
may be emailed to OHQ@hhs.gov, or by
mail to the following address: Public
Commentary, National Clinical Care
Commission, 1101 Wootton Parkway,
Suite 420, Rockville, MD 20852. Written
comments should not exceed three
pages in length.
DATES:
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
5671
Individuals who need special
assistance with reasonable
accommodations, should indicate the
special accommodation when
registering online or by notifying
Jennifer Gillissen at jennifer.gillissen@
kauffmaninc.com by February 7, 2020.
Authority: The National Clinical Care
Commission is required under the
National Clinical Care Commission Act
(Pub. L. 115–80). The Commission is
governed by provisions of the Federal
Advisory Committee Act (FACA), Public
Law 92–463, as amended (5 U.S.C.,
App.) which sets forth standards for the
formation and use of federal advisory
committees.
Dated: January 23, 2020.
Donald Wright,
Deputy Assistant Secretary for Health.
[FR Doc. 2020–01871 Filed 1–30–20; 8:45 am]
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Presidential Advisory
Council on Combating AntibioticResistant Bacteria
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that a meeting is scheduled to be held
for the Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria
(PACCARB). The meeting will be open
to the public; a public comment session
will be held during the meeting. Preregistration is required for members of
the public who wish to attend the
meeting and who wish to participate in
the public comment session. Individuals
who wish to attend the meeting and/or
send in their public comment via email
should send an email to CARB@hhs.gov.
Registration information is available on
the website https://www.hhs.gov/paccarb
and must be completed by February 19,
2020; all in-person attendees must preregister by this date. Additional
information about registering for the
meeting and providing public comment
can be obtained at https://www.hhs.gov/
paccarb on the Meetings page.
DATES: The meeting is scheduled to be
held on February 26, 2020, from 9:00
a.m. to 4:30 p.m. and February 27, 2020,
from 9:00 a.m. to 4:00 p.m. ET (times are
tentative and subject to change). The
confirmed times and agenda items for
SUMMARY:
E:\FR\FM\31JAN1.SGM
31JAN1
Agencies
[Federal Register Volume 85, Number 21 (Friday, January 31, 2020)]
[Notices]
[Pages 5670-5671]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01810]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
National Advisory Committee on Rural Health and Human Services
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Secretary's National Advisory Committee on
Rural Health and Human Services (NACRHHS) has scheduled a public
meeting. Information about NACRHHS and the agenda for this meeting can
be found on the NACRHHS website at https://www.hrsa.gov/advisory-committees/rural-health/.
DATES: March 2, 2020, 8:30 a.m.-5:15 p.m. Eastern Time (ET); March 3,
2020, 8:30 a.m.-5:15 p.m. ET; and March 4, 2020, 8:30 a.m.-11:15 a.m.
ET.
ADDRESSES: The address for the meeting is the Center for Disease
Control and Prevention (CDC) Global Communications Center (GCC)
Auditorium B3, 1600 Clifton Road, Atlanta, GA 30329.
On the morning of March 3, 2020, NACRHHS will break into
subcommittees. One subcommittee will travel to Mercer School of
Medicine, 1550 College St., Macon, GA 31207. The other subcommittee
will travel to Health Services Center, 608 Martin Luther King Drive,
Hobson City, AL 36201. In the afternoon, at approximately 4:00 p.m.
ET., NACRHHS will reconvene at the CDC GCC.
FOR FURTHER INFORMATION CONTACT: Steven Hirsch, Administrative
Coordinator at the Federal Office of Rural Health Policy, HRSA, 5600
Fishers Lane, 17W59D, Rockville, Maryland 20857; 301-443-7322; or
[email protected].
SUPPLEMENTARY INFORMATION: NACRHHS provides advice and recommendations
to the Secretary of HHS (Secretary) on policy, program development, and
other matters of significance concerning both rural health and rural
human services.
[[Page 5671]]
During the March 2-4, 2020, meeting, NACRHHS will examine two
topics: Maternal and Obstetric Care Challenges in Rural America and HIV
Prevention and Treatment Challenges in Rural America. Refer to the
NACRHHS website for any updated information concerning the meeting.
Members of the public will have the opportunity to provide
comments. Public participants may submit written statements in advance
of the scheduled meeting. Oral comments will be honored in the order
they are requested and may be limited as time allows. Requests to
submit a written statement or make oral comments to NACRHHS should be
sent to Steven Hirsch, using the contact information above, at least 3
business days prior to the meeting.
Individuals who plan to attend and need special assistance or
another reasonable accommodation should notify Steven Hirsch at the
address and phone number listed above at least 10 business days prior
to the meeting. Since the meeting at the CDC occurs in a federal
government building, attendees must go through a security check to
enter the building. Non-U.S. Citizen attendees must notify Steven
Hirsch of their planned attendance at least 20 business days prior to
the meeting in order to facilitate their entry into the building. All
attendees are required to present government-issued identification
prior to entry.
Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2020-01810 Filed 1-30-20; 8:45 am]
BILLING CODE 4165-15-P